Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001494695-25-000006·Manning Paul B
Schedule 13D ownership disclosure
VERRICA PHARMACEUTICALS INC
Common Stock, $0.0001 par value per share · CUSIP: 92511W207
Event date: 2025-11-25
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Paul B ManningReported CIK 0001494695
Shares: 8,056,031.00 · Class: 49.9%
- PBM Capital Investments, LLC
Shares: 25,663.00 · Class: 0.2%
- BKB Growth Investments, LLC
Shares: 3,348,372.00 · Class: 20.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001494695-25-000006
- Form type
- SCHEDULE 13D/A
- Filer
- Manning Paul B
- CIK
- CIK 1494695
- Filed
- Nov 28, 2025
- Reporting period
- Nov 25, 2025
- Description
- Schedule 13D beneficial ownership